GC Biopharma Corp. Single Sales/Supply Contract
GAI summary · Not investment advice
GC Biopharma signed a KRW 59.2 billion influenza vaccine supply contract with VaxThera Zona Franca S.A.S. for Colombia on 2026.10.30.
Contract amount
KRW 59.2 billion
Key facts
- Contract details
- Flu vaccine supply contractOther sales/supply contract
- Recent revenue
- KRW 2.0 trillionBased on 2025 consolidated financial statements
- % of revenue
- 2.97%
- Counterparty
- VaxThera Zona Franca S.A.S.
- Contract period
- Oct 30, 2026 – Oct 30, 2036
- Payment terms
- No down payment or advance paymentNo down payment or advance payment
- Contract date
- Oct 30, 2026
Earlier Single Sales/Supply Contract filings from this company
| Filed | Counterparty | Contract amount | % of revenue |
|---|---|---|---|
| 24.08.132024.08.13 | BLAU Farmaceutica S.A. | KRW 142.1 billion | 8.30% |
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist